Galapagos NV glpg.com

Galapagos is a clinical stage biotech company focused on developing novel medicines. Galapagos' most advanced candidate drug GLPG0634 shows excellent safety and efficacy in rheumatoid arthritis patients and is fully proprietary to Galapagos. With GLPG0634, Galapagos demonstrates its capabilities in developing novel medicines for difficult to cure diseases.

Galapagos is a clinical stage biotech company focused on developing novel medicines. Galapagos' most advanced candidate drug GLPG0634 shows excellent safety and efficacy in rheumatoid arthritis patients and is fully proprietary to Galapagos. With GLP...Show all

See All Exits Recent Exits

Phone: +32 15 34 29 00

Fax:

Industriepark Mechelen Noord
Generaal De Wittelaan L11 A3
Mechelen, 2800
Belgium

Galapagos NV - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2010-02-03ArgentaAcquired
2006-12-06InpharmaticaAcquired
2005-09-21BioFocusAcquired
See all 3 investments